The Thrombectomy Dilemma in Stroke Patients With Active Cancer: To Treat or Not to Treat?
Journal of Stroke · 31.05.2026 · 28 (2) · 218-227
DOI: 10.5853/jos.2026.00262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Stroke, erschienen am 31.05.2026. Verfasst von Yohanna Kusuma und 18 weiteren Autor:innen. Beteiligte Einrichtung: The University of Melbourne, Faculty of Medicine, Dentistry and Health Services, Melbourne, Australia. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Endovascular thrombectomy for acute large-vessel occlusion in patients with active cancer remains a difficult clinical decision. Multiple cohort studies and meta-analyses indicate that, when standard imaging and clinical criteria are applied, reperfusion success is high and symptomatic intracranial hemorrhage is broadly comparable with non-cancer populations, arguing against categorical exclusion. At the same time, registries show lower 90-day functional independence and higher 90-day mortality in active-cancer cohorts—effects likely driven by malignancy-related systemic factors and pre-existing functional compromise rather than procedural harm. This narrative review synthesizes efficacy and safety signals, highlights decision-grade outcomes that are seldom reported—early neurological change, performance status around 90 days, and whether systemic anticancer therapy is started or resumed. It sets out a clinical–ethical–economic framework to support selection, consent, and aftercare, including a pragmatic pathway for under-resourced settings based on non-contrast computed tomography (CT) or single-phase CT angiography where advanced perfusion imaging or magnetic resonance imaging are unavailable. We outline an Asia–Pacific collaborative program designed to identify subgroups that may benefit from reperfusion and initiation of active cancer care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The University of Melbourne, Faculty of Medicine, Dentistry and Health Services, Melbourne, Australia.
- The Royal Melbourne Hospital, Melbourne Brain Centre, Melbourne, Australia.
- Department of Neurology, Airlangga University, Surabaya, Indonesia.
- Department of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Neurology, College of Medicine, Seoul National University, Gyeonggi Regional Cerebrovascular Center, Seongnam, Korea.
- Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Zitieren
APA
Kusuma, Y., Beppu, M., Kim, B. J., Tang, S. C., Hayakawa, M., Yamagami, H., Kawano, H., Hirano, T., Yoshimura, S., Basri, H., Li, R., Nguyen, H. T., De Silva, D. A., Hong, K. S., Jeng, J. S., Phan, T. G., Ma, H., Yan, B., & Asia–Pacific Stroke–Cancer Consortium Investigators (2026). The Thrombectomy Dilemma in Stroke Patients With Active Cancer: To Treat or Not to Treat?. Journal of Stroke, 28(2), 218-227. https://doi.org/10.5853/jos.2026.00262
Vancouver
Kusuma Y, Beppu M, Kim BJ, Tang SC, Hayakawa M, Yamagami H, et al. The Thrombectomy Dilemma in Stroke Patients With Active Cancer: To Treat or Not to Treat?. Journal of Stroke. 2026;28(2):218-227. doi:10.5853/jos.2026.00262
BibTeX
@article{Kusuma2026,
author = {Kusuma, Yohanna and Beppu, Mikiya and Kim, Beom Joon and Tang, Sung-Chun and Hayakawa, Mikito and Yamagami, Hiroshi and Kawano, Hiroyuki and Hirano, Teruyuki and Yoshimura, Shinichi and Basri, Hamidon and Li, Richard and Nguyen, Huy Thang and De Silva, Deidre Anne and Hong, Keun-Sik and Jeng, Jiann-Shing and Phan, Than G and Ma, Henry and Yan, Bernard and Asia–Pacific Stroke–Cancer Consortium Investigators, Asia–Pacific Stroke–Cancer Consortium Investigators},
title = {The Thrombectomy Dilemma in Stroke Patients With Active Cancer: To Treat or Not to Treat?},
journal = {Journal of Stroke},
year = {2026},
volume = {28},
number = {2},
pages = {218--227},
doi = {10.5853/jos.2026.00262}
}
EUVIMED